Allotex

Boston, MA · Founded 2014 · Privately Held (backing)

Operator of an ophthalmic biologics and device company intended for the treatment of presbyopia, hyperopia and myopia. Allotex is based in Boston, MA and was founded in 2014. It was valued at $358 million at its early-stage round in Mar 2018, the last priced event on record. It has raised $46.8 million across 1 recorded round; the latest was a $16.7 million early-stage round in Feb 2018.

PMV mark · valuation
$358.0M
Oct 2026
Priced at
its early-stage round
Mar 2018
Total raised
$46.8M
Last round
Early Stage VC
Feb 2018
What is Allotex worth?
$358.0MPrivateMarketView mark · Oct 2026

Valued at $358.0M at its early-stage round, Mar 2018. Nothing has traded since.

Free account
More of Allotex with a free account
  • ·Watch Allotex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Allotex funding history

1 rounds
DateRoundRaisedPost-money
Feb 2018Early Stage VC$16.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Allotex valuation

Allotex was valued at $358 million at its early-stage round in Mar 2018. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Allotex raised?

Allotex has raised $46.8 million in total; 1 of its rounds is on record. The largest on record was a $16.7 million early-stage round in Feb 2018.

Allotex has filed 1 Form D with the SEC, most recently in Mar 2018 ($16.7 million sold to 2 investors).

How Allotex's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Allotex, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Allotex

What is Allotex worth?
Allotex is valued at $358.0M as of Oct 2026. Valued at $358.0M at its early-stage round, Mar 2018. Nothing has traded since.
How much has Allotex raised?
Allotex has raised $46.8M in total funding across 1 recorded rounds.
When did Allotex last raise?
Allotex last raised in Feb 2018 (Early Stage VC), raising $16.7M.